Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
12.9M
-
Shares change
-
+201K
-
Total reported value, excl. options
-
$492M
-
Value change
-
-$6.65M
-
Put/Call ratio
-
0.7
-
Number of buys
-
99
-
Number of sells
-
-104
-
Price
-
$38.12
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q3 2022
275 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.9M shares
of 30.2M outstanding shares and own 42.73% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.48M shares), VANGUARD GROUP INC (1.37M shares), STATE STREET CORP (756K shares), DIMENSIONAL FUND ADVISORS LP (681K shares), Pacer Advisors, Inc. (487K shares), Invesco Ltd. (410K shares), GEODE CAPITAL MANAGEMENT, LLC (396K shares), MORGAN STANLEY (289K shares), Bank of New York Mellon Corp (241K shares), and JPMORGAN CHASE & CO (193K shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.